Protagonist Therapeutics (PTGX) Non-Current Assets (2017 - 2025)
Historic Non-Current Assets for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $115.3 million.
- Protagonist Therapeutics' Non-Current Assets fell 930.38% to $115.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.1 million, marking a year-over-year increase of 17813.34%. This contributed to the annual value of $12.6 million for FY2024, which is 48664.5% up from last year.
- As of Q3 2025, Protagonist Therapeutics' Non-Current Assets stood at $115.3 million, which was down 930.38% from $115.5 million recorded in Q2 2025.
- Protagonist Therapeutics' Non-Current Assets' 5-year high stood at $136.3 million during Q1 2025, with a 5-year trough of $1.7 million in Q1 2024.
- Its 5-year average for Non-Current Assets is $36.2 million, with a median of $7.0 million in 2021.
- In the last 5 years, Protagonist Therapeutics' Non-Current Assets crashed by 8778.36% in 2022 and then surged by 780899.59% in 2025.
- Quarter analysis of 5 years shows Protagonist Therapeutics' Non-Current Assets stood at $7.0 million in 2021, then plummeted by 33.52% to $4.6 million in 2022, then crashed by 53.55% to $2.1 million in 2023, then skyrocketed by 486.64% to $12.6 million in 2024, then skyrocketed by 814.29% to $115.3 million in 2025.
- Its last three reported values are $115.3 million in Q3 2025, $115.5 million for Q2 2025, and $136.3 million during Q1 2025.